30 likes | 40 Views
Increasing prevalence cancer, auto-immune disease or other life threatening disease and use of specifically targeting biopharmaceutical products is driving the growth of this market.<br>
E N D
Glycan Analysis Market to See Incredible Growth During 2017 -2025 Therapeutic monoclonal antibodies (mAbs) are glycoproteins produced by living cell systems and the process is known as protein glycosylation. The glycan moieties attached to the proteins directly affects in-vivo bioactivity, stability, solubility and metabolic activity of bio therapeutics or biopharmaceutical products. Glycosylation is a post-translational modification and, is a non- template driven enzymatic modification process. Its structure largely depends up on production methods and conditions. Due to this reason the product can change when it is being prepared. Biopharmaceutical products including monoclonal antibodies and other recombinant products such as, growth factors, hormones, cytokines and therapeutic enzymes which are approved or under development for the treatment of life threatening condition. Bioavailability and stability of these biopharmaceutical products depend on glycan moieties attached to them. Therefore glycan moiety of protein product must be analysed and controlled properly to ensure quality of product. Request for Table of Contents @ https://www.persistencemarketresearch.com/toc/15712 Increasing use of biopharmaceutical products is major factor driving the growth of glycan analysis market. Increasing prevalence cancer, auto-immune disease or other life threatening disease and use of specifically targeting biopharmaceutical products is driving the growth of this market. Increasing focus of pharmaceutical companies and research institutes is also driving growth in this market. Complexity of protein glycosylation pauses a challenge in the for the glycan analysis. Over the past few years use of biopharmaceutical products in increasing due to the targeted action. These biopharmaceutical products are being approved by regulatory agencies as these are
more effective in treating life threatening and genetic disease. Due to these factors glycan analysis market is expected to show significant growth over the forecast period. Other factors which are expected to contribute in the growth of glycan analysis market is increasing production of biosimilars. As glycan analysis is essential method for analysing and controlling quality glycoproteins which are used in manufacturing and development of biosimilars. Mass spectroscopy segment is expected to be fastest and highest revenue generating analysis segment of glycan analysis market due to high accuracy of mass spectroscopy in defining structure of glycan. Among the end user segment biopharmaceutical companies is expected to be most attractive and highest revenue generating segment of glycan analysis market over the forecast period attributing to the focus of these companies on development of biosimilars products. Research institutes segment is also expected to show significant growth as major focus of this segment is on development of biopharmaceutical products for treatment of life threatening disease. Geographically, the global glycan analysis market can be segmented into North America, Latin America, Europe, Asia Pacific and Middle East & Africa. North America market is expected to be most attractive and highest revenue generating glycan analysis market owning to the factor that North America is biggest biopharmaceutical market and major players are present in this region. Fast approval of biopharmaceutical products by regulatory agency is also driving the growth of glycan analysis market in this region. Followed by which is Europe. Asia-Pacific is expected to be fastest growing market due to the presence of strong generic manufacturers and focus of key players on this region. Request to View Sample of Research Report @ https://www.persistencemarketresearch.com/samples/15712 Some of the key players in global glycan analysis market are Sartorius Stedim BioOutsource Limited, S-Bio Vaupell Holdings, Inc., ProZyme, Thermo Fisher Scientific,Waters Corp. About Us Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi- disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes. Contact Us Persistence Market Research 305 Broadway
7th Floor, New York City, NY 10007, United States, Telephone – +1-646-568-7751 USA – Canada Toll Free: 800-961-0353 Email: sales@persistencemarketresearch.com Web: http://www.persistencemarketresearch.com